01 CUPRIC SULFATE (1)
01 ABRAXIS PHARM (1)
01 INJECTABLE;INJECTION (1)
01 EQ 0.4MG COPPER/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (1)
01 USA (1)
19
ABRAXIS PHARM, based in U.S.A, is a pharmaceutical company.
One of their notable products is CUPRIC SULFATE, with a corresponding application number 19350 and regulatory information .
proudly manufactured in the
approval since 1987-05-05
ABRAXIS PHARM's CUPRIC SULFATE INJECTABLE;INJECTION, medication with EQ 0.4MG COPPER/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** of CUPRIC SULFATE.